Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Atropine
Drug ID BADD_D00189
Description An alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.
Indications and Usage For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides.
Marketing Status Prescription; Discontinued
ATC Code A03BA01; S01FA01
DrugBank ID DB00572
KEGG ID D00113
MeSH ID D001285
PubChem ID 174174
TTD Drug ID D0RG3O
NDC Product Code 69205-034; 60592-049; 11704-105; 63827-1015; 13371-488; 12714-034; 11704-106; 64181-0048; 11704-107; 11704-101; 11704-104
Synonyms Atropine | Atropinol | Atropine Sulfate | Sulfate, Atropine | Atropine Sulfate Anhydrous | Anhydrous, Atropine Sulfate | Sulfate Anhydrous, Atropine | AtroPen | Atropin Augen?l | Augen?l, Atropin
Chemical Information
Molecular Formula C17H23NO3
CAS Registry Number 51-55-8
SMILES CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Conjunctivitis allergic06.04.01.003; 10.01.04.002--Not Available
Constipation07.02.02.001--
Cough22.02.03.0010.000687%
Cyanosis02.01.02.002; 22.02.02.007; 24.03.01.007--
Cycloplegia06.05.03.002; 17.17.02.003--Not Available
Death08.04.01.001--
Dehydration14.05.05.001--
Delirium19.13.02.0010.001373%
Depressed level of consciousness17.02.04.002--
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004--Not Available
Diarrhoea07.02.01.001--
Diplopia06.02.06.002; 17.17.01.0050.000687%Not Available
Disorientation17.02.05.015; 19.13.01.002--Not Available
Dizziness02.01.02.004; 17.02.05.003; 24.06.02.007--
Drug hypersensitivity10.01.01.0010.006523%Not Available
Dry eye06.08.02.001--
Dry mouth07.06.01.0020.001030%
Dry skin23.03.03.001--
Dysarthria17.02.08.001; 19.19.03.0010.001030%
Dysgeusia07.14.03.001; 17.02.07.003--
Dysmetria17.02.02.005--Not Available
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dyspnoea02.01.03.002; 22.02.01.004--
Dysuria20.02.02.002--
Eczema23.03.04.006--
Electrocardiogram QRS complex13.14.05.034--Not Available
Electrocardiogram QT prolonged13.14.05.004--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene